Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -161.19% is 346% below its 5-year average of -36.16%, near the low end of its 5-year range (-161.19%–-21.15%).
As of the fiscal period ended Tuesday, June 30, 2026. 133.84% below its 12-month average of -68.93%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -161.19%.
RETURN ON EQUITY (ROE)
-161.19%
RETURN ON EQUITY (ROE) AVG TTM
-68.93%
RETURN ON EQUITY (ROE) AVG 3Y
-38.77%
RETURN ON EQUITY (ROE) AVG 5Y
-36.16%
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-133.84%
CURRENT VS 3Y AVG
-315.80%
CURRENT VS 5Y AVG
-345.72%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-41.78%
median of 740 covered companies
CURRENT VS SECTOR MEDIAN
-285.75%
vs the sector median at left
Nano-X Imaging Ltd.
Market Cap
$43.59M
Return on Equity (ROE)
-161.19%
TTM Avg
-68.93%
3Y Avg
-38.77%
5Y Avg
-36.16%
Market Cap
$43.38M
Return on Equity (ROE)
513.56%
TTM Avg
488.17%
3Y Avg
265.30%
5Y Avg
226.12%
Market Cap
$43.92M
Return on Equity (ROE)
-288.49%
TTM Avg
-102.07%
3Y Avg
-71.41%
5Y Avg
-78.05%
Market Cap
$44.75M
Return on Equity (ROE)
123.04%
TTM Avg
-60.38%
3Y Avg
-75.18%
5Y Avg
-82.51%
Market Cap
$44.85M
Return on Equity (ROE)
-260.45%
TTM Avg
-109.97%
3Y Avg
-78.03%
5Y Avg
-56.14%
Market Cap
$42.12M
Return on Equity (ROE)
-102.45%
TTM Avg
30.59%
3Y Avg
217.16%
5Y Avg
155.68%
Market Cap
$45.20M
Return on Equity (ROE)
-212.45%
TTM Avg
-170.64%
3Y Avg
-104.70%
5Y Avg
-78.05%
Market Cap
$41.92M
Return on Equity (ROE)
-8.23%
TTM Avg
-18.98%
3Y Avg
-38.34%
5Y Avg
-43.89%
Market Cap
$41.81M
Return on Equity (ROE)
-47.96%
TTM Avg
-120.47%
3Y Avg
-203.88%
5Y Avg
-145.61%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nano-X Imaging Ltd. (NNOX) | $43.59M | -161.19% | -68.93% | -38.77% | -36.16% |
| SANUWAVE Health Inc. (SNWV)vs › | $43.38M | 513.56% | 488.17% | 265.30% | 226.12% |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $43.92M | -288.49% | -102.07% | -71.41% | -78.05% |
| DarioHealth Corp. (DRIO)vs › | $44.75M | 123.04% | -60.38% | -75.18% | -82.51% |
| CVRx, Inc. (CVRX)vs › | $44.85M | -260.45% | -109.97% | -78.03% | -56.14% |
| BioStem Technologies, Inc. (BSEM)vs › | $42.12M | -102.45% | 30.59% | 217.16% | 155.68% |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $45.20M | -212.45% | -170.64% | -104.70% | -78.05% |
| Precipio, Inc. (PRPO)vs › | $41.92M | -8.23% | -18.98% | -38.34% | -43.89% |
| Veru Inc. (VERU)vs › | $41.81M | -47.96% | -120.47% | -203.88% | -145.61% |
| Filana Therapeutics, Inc. (FLNA)vs › | $40.48M | -66.47% | -61.13% | -30.57% | -24.45% |
ROE
-161.2%
ROA
-128.1%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -161.19% |
| 2026-03-31 | -60.21% |
| 2025-12-31 | -53.69% |
| 2025-09-30 | -35.55% |
| 2025-06-30 | -34.03% |
| 2025-03-31 | -30.77% |
| 2024-12-31 | -28.30% |
| 2024-09-30 | -30.33% |
| 2024-06-30 | -32.81% |
| 2024-03-31 | -33.12% |
| 2023-12-31 | -31.09% |
| 2023-09-30 | -47.20% |
| 2023-06-30 | -48.10% |
| 2023-03-31 | -46.12% |
| 2022-12-31 | -48.57% |
| 2022-09-30 | -33.26% |
| 2022-06-30 | -29.28% |
| 2022-03-31 | -25.54% |
| 2021-12-31 | -21.15% |
| 2021-09-30 | -28.22% |
| 2021-06-30 | -25.94% |
| 2021-03-31 | -21.80% |
| 2020-12-31 | -18.99% |
| 2020-09-30 | -18.35% |
| 2020-06-30 | -85.91% |
